Issue link: http://deals.uberflip.com/i/1538899
Innova ve Medical Safety Solu ons Patented Provider—Electronic Sensors #55662 BUSINESS HIGHLIGHTS This Company is a leading developer, manufacturer, marketer, and distributor of specialized electronic sensors, controls, and systems designed to prevent ferrous-based objects from becoming hazardous projec les in MRI environments. The Company's patented detec on and warning devices are u lized in hospitals, radiological imaging clinics, universi es, and mobile MR laboratories, ensuring the safety of pa ents, medical personnel, and equipment. With a strong focus on innova on, the Company addresses a cri cal safety issue in the medical industry, recognized by major safety organiza ons and regulatory agencies. The Company holds 22 worldwide patents, offering a complete line of products and maintaining a significant market posi on. The Company has a robust interna onal presence, supported by an extensive distributor network and a dedicated European subsidiary. The Company's commitment to quality is demonstrated by its compliance with ISO 9001-2015 standards, facilita ng addi onal opportuni es with OEMs. The Company has a diverse customer base, including hospitals, imaging centers, and government en es, with a high rate of repeat business. The Company's financial stability is underscored by a substan al backlog of signed contracts and a consistent revenue stream. Barry DeWi Managing Director - M&A E. bdewi @genera onal.com T. 727-415-1487 INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 - 2022 - 2024 DISCLAIMER: All informa on contained in this document has been provided by the subject company to Genera onal Equity and while believed to be correct has not been verified. Accordingly, Genera onal Equity makes no representa ons or warran es as to the accuracy and truthfulness of such informa on. The recipient hereof acknowledges that Genera onal Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Genera- onal Equity of this document. At all mes Genera onal Equity and/or its affiliate network members are agents for the seller and not for the buyer. Genera onal Equity's fees are paid by the seller. INVESTMENT APPEAL Patented Products: The Company holds 22 worldwide patents, effec vely blocking new entrants and limi ng exis ng compe tors. Financial Stability: A substan al backlog of signed contracts ensures a steady revenue stream and underscores the Company's financial health. Regulatory Compliance: Compliance with ISO 9001-2015 and adherence to stringent safety standards enhance the Company's credibility and market opportuni es. Interna onal Reach: The Company's extensive distributor network and European subsidiary minimize geographic economic risk and support global market expansion. Favorable Demographics: The aging US popula on and increasing healthcare spending drive demand for the Company's products. Strategic Growth Opportuni es: Expansion into interna onal markets and new product lines present significant growth poten al. Genera onal Equity 360 Central Ave. Ste.829 St. Petersburg, FL 33701 SIGN NDA ► $1.6M $7.0M 2025 REVENUE (PROJ) 2025 EBITDA (PROJ) REVENUE / EBITDA KEY CUSTOMERS Customer A (11 Years): 10% Customer B (16 Years): 10% Customer C (12 Years): 6% Customer D (11 Years): 6% $1.4M $6.3M 2024 REVENUE 2024 EBITDA GEOGRAPHIC MARKETS USA: 77% Asia: 9% Europe: 5% Middle East: 5% Other: 4% HISTORICAL AND PRO FORMA FINANCIALS REVENUE SOURCES